Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Sep-22 4:32 PM View:  | Rich Stuart Chief Medical Officer Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 21-Sep-22 | Gift | 1,909,580 | -- | -- | (31%) 6.15M to 4.24M | |
| 23-Sep-22 4:32 PM View: | Rich Stuart Chief Medical Officer Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 21-Sep-22 | Gift | 1,909,580 | -- | -- | 45% 4.24M to 6.15M | |
| 12-Aug-22 4:24 PM View: | Doogan Declan Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 11-Aug-22 | Gift | 567,871 | -- | -- | 16% 3.64M to 4.21M | |
| 12-Aug-22 4:24 PM View: | Doogan Declan Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 11-Aug-22 | Gift | 567,871 | -- | -- | (14%) 4.21M to 3.64M | |
| 06-Dec-21 5:08 PM View: | Rich Stuart Chief Medical Officer Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 29-Nov-21 | Gift | 1,909,580 | -- | -- | 45% 4.24M to 6.15M | |
| 06-Dec-21 5:08 PM View: | Rich Stuart Chief Medical Officer Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 29-Nov-21 | Gift | 1,909,580 | -- | -- | (31%) 6.15M to 4.24M | |
| 06-Dec-21 5:08 PM View: | Rich Stuart Chief Medical Officer Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 12-Oct-21 | Gift | 1,909,580 | -- | -- | (31%) 6.15M to 4.24M | |
| 06-Dec-21 5:08 PM View: | Rich Stuart Chief Medical Officer Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 12-Oct-21 | Gift | 1,909,580 | -- | -- | 45% 4.24M to 6.15M | |
| 11-Aug-21 4:30 PM View: | Doogan Declan Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 30-Jun-21 | Gift | 567,871 | -- | -- | (16%) 3.64M to 3.07M | |
| 15-Jun-21 4:34 PM View: | Rich Stuart Chief Medical Officer Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 11-Jun-21 | Option Exercise | 3,581,000 | -- | -- | 541% 662.52K to 4.24M | |
| 15-Jun-21 4:34 PM View: | Davidson Michael H. Director | Tenax Therapeutics, Inc. (TENX) | 11-Jun-21 | Grant | 512,000 | -- | -- | 541% 94.64K to 606.64K | |
| 15-Jun-21 4:34 PM View: | Doogan Declan Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 11-Jun-21 | Option Exercise | 3,070,000 | -- | -- | 541% 567.87K to 3.64M | |
| 27-Jan-21 4:33 PM View: | Rich Stuart Chief Medical Officer | Tenax Therapeutics, Inc. (TENX) | 15-Jan-21 | Grant | 666,098 | -- | -- | 100% 0 to 666.1K | |
| 09-Sep-20 7:04 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 08-Sep-20 | Market Purchase | 8,543 | $1.46 | $12,472.80 | < 1% 4.03M to 4.04M | |
| 09-Sep-20 7:04 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 08-Sep-20 | Purchase | -- | -- | -- | 0% 4.04M | |
| 09-Sep-20 7:04 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 04-Sep-20 | Purchase | -- | -- | -- | 0% 4.02M | |
| 09-Sep-20 7:04 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 04-Sep-20 | Market Purchase | 23,457 | $1.41 | $33,074.40 | < 1% 4.0M to 4.02M | (6%) |
| 03-Sep-20 5:39 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 03-Sep-20 | Market Purchase | 36,000 | $1.39 | $50,040.00 | < 1% 3.94M to 3.98M | |
| 03-Sep-20 5:39 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 03-Sep-20 | Purchase | -- | -- | -- | 0% 3.98M | |
| 03-Sep-20 5:39 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 02-Sep-20 | Market Purchase | 20,000 | $1.47 | $29,400.00 | < 1% 3.88M to 3.9M | |
| 03-Sep-20 5:39 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 02-Sep-20 | Purchase | -- | -- | -- | 0% 3.9M | |
| 03-Sep-20 5:39 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 01-Sep-20 | Purchase | -- | -- | -- | 0% 3.86M | |
| 03-Sep-20 5:39 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 01-Sep-20 | Market Purchase | 30,000 | $1.46 | $43,800.00 | < 1% 3.83M to 3.86M | (10%) |
| 31-Aug-20 7:38 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 31-Aug-20 | Market Purchase | 20,000 | $1.45 | $29,000.00 | < 1% 3.78M to 3.8M | |
| 31-Aug-20 7:38 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 31-Aug-20 | Purchase | -- | -- | -- | 0% 3.8M | |
| 31-Aug-20 7:38 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 27-Aug-20 | Market Purchase | 12,000 | $1.50 | $18,000.00 | < 1% 3.75M to 3.76M | (12%) |
| 31-Aug-20 7:38 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 27-Aug-20 | Purchase | -- | -- | -- | 0% 3.76M | |
| 26-Aug-20 5:47 PM View: | Armistice Capital, LLC 10% Owner | Tenax Therapeutics, Inc. (TENX) | 26-Aug-20 | Purchase | -- | -- | -- | 0% 3.74M | |
| 26-Aug-20 5:47 PM View: | Armistice Capital, LLC 10% Owner | Tenax Therapeutics, Inc. (TENX) | 26-Aug-20 | Market Purchase | 12,000 | $1.50 | $18,000.00 | < 1% 3.73M to 3.74M | |
| 26-Aug-20 5:47 PM View: | Armistice Capital, LLC 10% Owner | Tenax Therapeutics, Inc. (TENX) | 25-Aug-20 | Market Purchase | 17,211 | $1.53 | $26,332.80 | < 1% 3.7M to 3.72M | |
| 26-Aug-20 5:47 PM View: | Armistice Capital, LLC 10% Owner | Tenax Therapeutics, Inc. (TENX) | 25-Aug-20 | Purchase | -- | -- | -- | 0% 3.72M | |
| 26-Aug-20 5:47 PM View: | Armistice Capital, LLC 10% Owner | Tenax Therapeutics, Inc. (TENX) | 24-Aug-20 | Market Purchase | 5,692 | $1.47 | $8,367.24 | < 1% 3.68M to 3.68M | (10%) |
| 26-Aug-20 5:47 PM View: | Armistice Capital, LLC 10% Owner | Tenax Therapeutics, Inc. (TENX) | 24-Aug-20 | Purchase | -- | -- | -- | 0% 3.68M | |
| 21-Aug-20 5:56 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 21-Aug-20 | Purchase | -- | -- | -- | 0% 3.67M | |
| 21-Aug-20 5:56 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 21-Aug-20 | Market Purchase | 116,242 | $1.44 | $167,388.00 | 3% 3.55M to 3.67M | |
| 21-Aug-20 5:56 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 20-Aug-20 | Market Purchase | 124,472 | $1.53 | $190,442.00 | 4% 3.31M to 3.44M | |
| 21-Aug-20 5:56 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 20-Aug-20 | Purchase | -- | -- | -- | 0% 3.44M | |
| 21-Aug-20 5:56 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 19-Aug-20 | Market Purchase | 70,767 | $1.45 | $102,612.00 | 2% 3.12M to 3.19M | (9%) |
| 21-Aug-20 5:56 PM View: | Armistice Capital, LLC Director 10% Owner | Tenax Therapeutics, Inc. (TENX) | 19-Aug-20 | Purchase | -- | -- | -- | 0% 3.19M | |
| 19-May-20 4:31 PM View: | Blanck Ronald R Director | Tenax Therapeutics, Inc. (TENX) | 18-May-20 | Market Purchase | 5,000 | $0.95 | $4,774.00 | 471% 1.06K to 6.06K | |
| 07-Aug-18 10:15 AM View: | Jebsen Michael B CFO | Tenax Therapeutics, Inc. (TENX) | 31-Jul-18 | Disposition | 5,720 | $6.25 | $35,750.00 | 20% 28.96K to 34.68K | (80%) |
| 05-Apr-18 8:08 PM View: | Jebsen Michael B CFO | Tenax Therapeutics, Inc. (TENX) | 30-Mar-18 | Disposition | 6,425 | $5.42 | $34,823.50 | 109% 5.88K to 12.31K | (77%) |
| 02-Jan-18 1:51 PM View: | Jebsen Michael B CFO | Tenax Therapeutics, Inc. (TENX) | 29-Dec-17 | Disposition | 98 | $0.43 | $42.14 | < 1% 68.17K to 68.26K | 205% |
| 20-Dec-17 9:50 AM View: | Blanck Ronald R Director | Tenax Therapeutics, Inc. (TENX) | 18-Dec-17 | Market Purchase | 12,950 | $0.45 | $5,887.07 | 181% 7.15K to 20.1K | (86%) |
| 20-Nov-17 12:20 PM View: | Blanck Ronald R Director | Tenax Therapeutics, Inc. (TENX) | 14-Nov-17 | Market Sale | 12,950 | $0.39 | $5,050.50 | (64%) 20.1K to 7.15K | 84% |
| 31-Jul-17 10:46 AM View: | Jebsen Michael B CFO | Tenax Therapeutics, Inc. (TENX) | 31-Jul-17 | Disposition | 54 | $0.65 | $35.10 | < 1% 68.09K to 68.15K | |
| 18-Apr-17 8:24 AM View: | Jebsen Michael B CFO | Tenax Therapeutics, Inc. (TENX) | 15-Apr-17 | Disposition | 56 | $0.54 | $30.24 | < 1% 68.14K to 68.2K | |
| 20-Mar-17 7:29 PM View: | Kelley John P Chief Executive Officer Director | Tenax Therapeutics, Inc. (TENX) | 15-Mar-17 | Grant | 213,420 | -- | -- | 18% 1.17M to 1.38M | |
| 20-Mar-17 7:29 PM View: | Kelley John P Chief Executive Officer Director | Tenax Therapeutics, Inc. (TENX) | 15-Mar-17 | Payment of Exercise | 96,999 | $0.68 | $65,959.30 | (7%) 1.38M to 1.28M | 92% |
| 20-Dec-16 10:12 AM View: | Jebsen Michael B Chief Financial Officer | Tenax Therapeutics, Inc. (TENX) | 19-Dec-16 | Disposition | 49 | $2.07 | $101.43 | < 1% 68.21K to 68.26K |
